Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Bioventus, Inc.

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reports Second Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Names Robert Claypoole as President and Chief Executive Officer
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Present at the Cantor Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Completes Divestiture of its Wound Business
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Announces Divestiture of its Wound Business
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Announces CEO Leadership Change
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
From Bioventus, Inc.
Via GlobeNewswire
Tickers BVS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.